In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?

Archives of Disease in Childhood

Volumn 92, Issue 4, 2007, Pages 362-365

  Herd, David ^a  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PROCALCITONIN;

BACTERIAL INFECTION; CLINICAL EXAMINATION; FEVER; HUMAN; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED MEDICINE; FEVER; HUMANS; INFANT; MALE; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 34047219084     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.112441     Document Type: Note

References (13)

1. Hsiao AL, Baker MD. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr 2005;17(1):56-61.
2. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39(2):206-17.
3. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999;18(10):875-81.
4. Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenfer study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 2003;22(10):895-903.
5. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 2000;106(3):505-11.
6. Klein JO. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization. Pediatr Infect Dis J 2002;21(6):584-8; discussion 613-4.
7. Oster P, Lennon D, O'Hallahan J, et al. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 2005;23(17-18):2191-6.
8. Trautner BW, Caviness AC, Gerlacher GR, et al. Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature of 106 degrees F or higher). Pediatrics 2006;118(1):34-40.
9. Thayyil S, Shenoy M, Hamaluba M, et al. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005;94(2):155-8.
10. Nylen E, Muller B, Becker KL, et al. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 2003;36(6):823-4; author reply 826-7.
11. Lacour AG, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001;160(2):95-100.
12. Procalcitonin study: methodological errors. Available online at http://pediatrics.aappublications.org/cgi/eletters/112/5/1054 (accessed 5 February 2007).
13. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003;112(5):1054- 60.